/PRNewswire/ BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company s Investigational New Drug (IND).
/PRNewswire/ BioCity Biopharma, a clinical-stage biopharmaceutical company committed to developing novel and highly differentiated, modality-independent.